Background: The traditional methods used in the diagnosis of dengue in
fection do not lend themselves to field application. As such, clinical
specimens have to be sent to a central laboratory for processing whic
h invariably leads to delay. This affects patient management and disea
se control. The development of the dengue IgM dot enzyme immunoassay h
as opened up the possibility of carrying out the test in peripheral he
alth settings. Objectives: This multicentre study was conducted to eva
luate a new, commercial nitrocellulose membrane based IgM capture enzy
me immunoassay. Study design: The sensitivity and specificity of the t
est were compared with in-house dengue IgM enzyme-linked immunoassays
routinely performed by each of the selected centres. Known positive an
d negative dengue specimens, as well as specimens from non-dengue case
s, were included in the evaluation. Results: Based on 402 specimens te
sted by the six centres, the sensitivity was 92.1% and specificity 88.
1%, with an overall agreement of 92.8% when compared with IgM EIA assa
ys performed on microplates. Conclusions: The results suggest that thi
s commercial kit has a role to play in the diagnosis of dengue infecti
on, especially in peripheral hearth settings. (C) 1996 Elsevier Scienc
e B.V.